An analysis finds that pharmas frequently file multiple similar patents on drugs, then use them as the basis for questionable litigation against would-be competitors.
During a fireside chat at the AI Impact Summit, Google DeepMind CEO Demis Hassabis says today's AI systems remain 'jagged intelligences' as he outlines gaps in planning, creativity and safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results